Eyes On FDA As Trump, Docs Press Agency To Reissue Hydroxychloroquine EUA

By Beth Wang / July 8, 2020 at 8:03 PM
Stakeholders are closely watching to see whether FDA will cave to pressure from the White House and doctors and reinstate emergency use authorization for the anti-malarial drug hydroxychloroquine. Doctors with Detroit’s Henry Ford Health System requested FDA re-issue the EUA based on data from the health system’s observational study that suggest the drug reduced death rates in hospitalized COVID-19 patients. The agency revoked the drug’s EUA for use as a coronavirus treatment last month after data from clinical trials cast...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.